<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05112016</url>
  </required_header>
  <id_info>
    <org_study_id>TME-KSW</org_study_id>
    <nct_id>NCT05112016</nct_id>
  </id_info>
  <brief_title>Long-term Cohort Study of Mesorectal Excision for Rectal Cancer</brief_title>
  <acronym>TME-KSW</acronym>
  <official_title>Long-term Cohort Study of Mesorectal Excision for Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this cohort study is to record, evaluate and compare the surgical, oncological as&#xD;
      well as the functional outcome and Quality of life after mesorectal excision for rectal&#xD;
      cancer&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Outcomes of mesorectal excision patients will be analysed. Medical records will be reviewed&#xD;
      and perioperative outcomes retrieved, incl. long-term oncological and functional/quality of&#xD;
      life data. A retrospective cohort over 10 years (2007-2016) will serve as a control to a&#xD;
      prospective cohort over 10 further years (2017-2026) as to investigate trends in&#xD;
      perioperative and oncological outcomes (min. follow-up of 5 years + adequate cohort size).&#xD;
      Prospective data on bowel function, urogenital function and quality of life will measured at&#xD;
      time of diagnosis and further. Variations in neoadjuvant/adjuvant treatment and surgical&#xD;
      approaches will be assessed for their effect on the outcomes of interest.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2007</start_date>
  <completion_date type="Anticipated">July 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Perioperative mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Reporting perioperative mortality with Clavien-Dindo &amp; Comprehensive Complications Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Age</measure>
    <time_frame>10 years</time_frame>
    <description>Age (years)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body mass index</measure>
    <time_frame>10 years</time_frame>
    <description>BM (kg/m2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gender</measure>
    <time_frame>10 years</time_frame>
    <description>Sex (male, female)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ASA score</measure>
    <time_frame>10 years</time_frame>
    <description>American Society of Anesthesiologists score (I to V)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Date of surgery</measure>
    <time_frame>day of surgery</time_frame>
    <description>date of surgery (day-month-year)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tumor localisation</measure>
    <time_frame>10 years</time_frame>
    <description>Description of tumor localisation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comorbidities</measure>
    <time_frame>day of surgery</time_frame>
    <description>Charlson index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perioperative complications</measure>
    <time_frame>90 days</time_frame>
    <description>Reporting and grading of postoperative surgical complications (according to Dindo-Clavien classification and/or comprehensive complications index)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Histological results</measure>
    <time_frame>30 days</time_frame>
    <description>Histological staging and grading of the specimen by a pathologist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life, including functional and symptom scales, incontinence scores, sexual function</measure>
    <time_frame>10 years</time_frame>
    <description>taTME survey (validated english, german, french versions); from 0 (worst) to 100 (best)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative treatment</measure>
    <time_frame>10 years</time_frame>
    <description>Chemoradiation before or after surgery, other treatments necessary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery time</measure>
    <time_frame>day of surgery</time_frame>
    <description>Duration of surgery in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>90 days</time_frame>
    <description>Length of hospital stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>90 days</time_frame>
    <description>Number of patients readmitted within 90 days of index surgery divided by the total number of patients operated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>10 years</time_frame>
    <description>At the level of individual patient Cost in terms of hospital charges and expenses in Swiss Francs. Actual costs and micro-costing</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Rectum</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>TME for rectal cancer</arm_group_label>
    <description>Patients with rectal cancer treated by TME (laparoscopic TME, transanal TME, robotic TME, open TME)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total mesorectal excision for rectal cancer</intervention_name>
    <arm_group_label>TME for rectal cancer</arm_group_label>
    <other_name>TME</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with rectal cancer who benefit from surgical resection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and Women &gt;18 years&#xD;
&#xD;
          -  Patients with rectal cancer&#xD;
&#xD;
          -  Underwent mesorectal excision&#xD;
&#xD;
          -  Agreed to fill in a validated questionnaires before surgery and after stoma reversal&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18&#xD;
&#xD;
          -  No informed consent (no general consent, no consent to use personal data for research&#xD;
             purpose)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Adamina, Prof/MD/MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur KSW</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel Adamina, Prof/MD/MSc</last_name>
    <phone>+41522663376</phone>
    <email>michel.adamina@ksw.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kantonsspital Winterthur</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <state>ZÃ¼rich</state>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Adamina, Prof/MD/MSc</last_name>
      <phone>+41522663634</phone>
      <email>michel.adamina@ksw.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TME (total mesorectal excision)</keyword>
  <keyword>Transanal TME</keyword>
  <keyword>Laparoscopic TME</keyword>
  <keyword>Robotic TME</keyword>
  <keyword>Open TME</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

